Surescripts says US FTC antitrust suit failed to show foreclosure, anticompetitive effects in e-prescription markets
MLex Summary: The US Federal Trade Commission "cannot prove that a single competitor was foreclosed from entering the market" by Surescripts’ loyalty provisions for e-prescription eligibility and routing services, the company...To view the full article, register now.
Already a subscriber? Click here to view full article